STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Sana Biotechnology, Inc.

Filed

February 12, 2024

Period of Report

February 8, 2024

Accession Number

0001062993-24-002842